Casolino R, Mateo J, de Vries EGE, Johns A, Courtot M, Lawlor RT, Perdomo S, Gray SW, Perez-Lopez R, Turnbull C, Torrents D, Vokinger KN, Akhoundova D, Bourque JM, Cardona AF, Chang YJ, Chakravarty D, Chicherova I, Cranston KA, Davis M, Drury A, Frisell O, Garcia RM, Grossman RL, Hamdi Y, Hediger S, Hofmarcher T, Hofmann O, Kather JN, Kim H et al. (2026)
Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission
Lancet Oncol, 27 (10), e454-e507
DOI 10.1016/S1470-2045(26)00302-5, PubMed 42790448

Yaqub S, Valberg M, Bjørnbeth BA, Angelsen JH, Brudvik KW, Eilertsen IA, Fristedt R, Fristrup CW, Gilg S, Hemmingsson O, Isaksson B, Juel IS, Knudsen AR, Larsen PN, Mortensen KE, Olsen IC, Sandström P, Sandvik OM, Sparrelid E, Taflin H, Lothe RA, Taskén K, ASAC Study Group (2026)
Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
Lancet Gastroenterol Hepatol (in press)
DOI 10.1016/S2468-1253(26)00260-8, PubMed 42777749

Hermansen JU, Kong W, Brodersen AM, Yin Y, Urban A, Rein ID, He L, Agius R, Teglgaard RS, Rousu J, Brieghel C, Kersting S, Levin MD, Tran HTT, Mattsson M, Ranti J, Veldhuis GJ, da Cunha-Bang C, Mous R, Dubois J, Kater AP, Enserink JM, Niemann CU, Aittokallio T, Skånland SS (2026)
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax
Hemasphere, 10 (9), e70467
DOI 10.1002/hem3.70467, PubMed 42757031